Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglaret

Showing results (151-160 of 267) with videos related to

Pageof 27
Sort By:
Revue D'Epidemiologie Et De Sante Publique|October 28, 2022
[Primary isoniazid preventive therapy : A strategy still relevant in the era of test and treat ; literature review]D R Moh, A Badjé, A N Kassi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adultsAlbert K Minga, Xavier Anglaret, Thomas d' Aquin Toni, et al.
World Journal of Hepatology|August 3, 2012
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patientsKoffi Alain Attia, Serge Eholié, Eugène Messou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2001
HIV-1-related morbidity in adults, Abidjan, Côte d'Ivoire: a nidus for bacterial diseasesA Attia, C Huët, X Anglaret, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West AfricaCharlotte Lewden, Delphine Gabillard, Albert Minga, et al.
AIDS (London, England)|July 30, 2005
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysisYazdan Yazdanpanah, Elena Losina, Xavier Anglaret, et al.
Plos One|June 30, 2010
The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'IvoireArnousse Beaulière, Siaka Touré, Pierre-Kébreau Alexandre, et al.
Plos Neglected Tropical Diseases|March 25, 2016
A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in GuineaRomain Palich, Jean-Luc Gala, Frédéric Petitjean, et al.
American Journal of Epidemiology|October 26, 2016
What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO TrialKévin Jean, Marie-Claude Boily, Christine Danel, et al.
The Journal of Infectious Diseases|November 7, 2008
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adultsChristine Danel, Raoul Moh, Marie-Laure Chaix, et al.
Pageof 27

Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Revue D'Epidemiologie Et De Sante Publique|October 28, 2022
[Primary isoniazid preventive therapy : A strategy still relevant in the era of test and treat ; literature review]D R Moh, A Badjé, A N Kassi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adultsAlbert K Minga, Xavier Anglaret, Thomas d' Aquin Toni, et al.
World Journal of Hepatology|August 3, 2012
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patientsKoffi Alain Attia, Serge Eholié, Eugène Messou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2001
HIV-1-related morbidity in adults, Abidjan, Côte d'Ivoire: a nidus for bacterial diseasesA Attia, C Huët, X Anglaret, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West AfricaCharlotte Lewden, Delphine Gabillard, Albert Minga, et al.
AIDS (London, England)|July 30, 2005
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysisYazdan Yazdanpanah, Elena Losina, Xavier Anglaret, et al.
Plos One|June 30, 2010
The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'IvoireArnousse Beaulière, Siaka Touré, Pierre-Kébreau Alexandre, et al.
Plos Neglected Tropical Diseases|March 25, 2016
A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in GuineaRomain Palich, Jean-Luc Gala, Frédéric Petitjean, et al.
American Journal of Epidemiology|October 26, 2016
What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO TrialKévin Jean, Marie-Claude Boily, Christine Danel, et al.
The Journal of Infectious Diseases|November 7, 2008
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adultsChristine Danel, Raoul Moh, Marie-Laure Chaix, et al.
Pageof 27